What the Supreme Court’s Decision to Hear the Purdue Pharma Case Means
Posted inBankruptcies Compensation for Damages (Law) Decisions and Verdicts Drug Abuse and Traffic Justice Department Office of the United States Trustee Opioids and Opiates OxyContin (Drug) Purdue Pharma Sackler Family Suits and Litigation (Civil) Supreme Court (US)

What the Supreme Court’s Decision to Hear the Purdue Pharma Case Means

A federal appeals court had signed off on a deal that would shield members of the wealthy Sackler family from lawsuits in exchange for billions for those harmed by the opioid epidemic.
An Appeals Court Gave the Sacklers Legal Immunity. Here’s What the Ruling Means.
Posted inBankruptcies Decisions and Verdicts Drugs (Pharmaceuticals) Office of the United States Trustee Opioids and Opiates OxyContin (Drug) Pain-Relieving Drugs Purdue Pharma Sackler Family States (US) Suits and Litigation (Civil) U.S. Court of Appeals for the Second Circuit United States

An Appeals Court Gave the Sacklers Legal Immunity. Here’s What the Ruling Means.

In return for the shield, the billionaire owners of Purdue Pharma are committed to paying up to $6 billion to help compensate communities and individuals for the ravages of the opioid epidemic.
National Academies Members Demand Answers About Sacklers’ Donations
Posted inDrugs (Pharmaceuticals) National Academies of Sciences, Engineering and Medicine Opioids and Opiates OxyContin (Drug) Pain-Relieving Drugs Philanthropy Purdue Pharma Sackler Family Science and Technology United States United States Politics and Government

National Academies Members Demand Answers About Sacklers’ Donations

The Academies accepted millions of dollars from members of the Sackler family — including some who led Purdue Pharma, makers of OxyContin — even while advising federal officials on opioid policy.